Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novavax Inc (NVAX)

Novavax Inc (NVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,565,428
  • Shares Outstanding, K 78,135
  • Annual Sales, $ 1,146 M
  • Annual Income, $ -1,744 M
  • 60-Month Beta 1.59
  • Price/Sales 3.55
  • Price/Cash Flow N/A
  • Price/Book 62.33
Trade NVAX with:

Options Overview Details

View History
  • Implied Volatility 140.82% ( -10.28%)
  • Historical Volatility 128.07%
  • IV Percentile 89%
  • IV Rank 73.92%
  • IV High 168.44% on 12/06/21
  • IV Low 62.55% on 06/24/21
  • Put/Call Vol Ratio 0.82
  • Today's Volume 22,741
  • Volume Avg (30-Day) 13,938
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 282,041
  • Open Int (30-Day) 255,050

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 5.71
  • Number of Estimates 4
  • High Estimate 6.70
  • Low Estimate 4.62
  • Prior Year -4.75
  • Growth Rate Est. (year over year) +220.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.33 +29.25%
on 05/12/22
63.23 -15.51%
on 05/05/22
-0.27 (-0.50%)
since 04/20/22
3-Month
41.33 +29.25%
on 05/12/22
91.00 -41.30%
on 03/01/22
-28.47 (-34.77%)
since 02/18/22
52-Week
41.33 +29.25%
on 05/12/22
277.80 -80.77%
on 09/08/21
-92.97 (-63.51%)
since 05/20/21

Most Recent Stories

More News
Why Pfizer Stock Is Rising Today While Moderna and Novavax Are Sliding

Different dynamics are at work for these vaccine stocks.

PFE : 52.47 (+3.59%)
MRNA : 136.25 (-4.97%)
NVAX : 53.42 (-8.57%)
Will Novavax Stock Ever Reach Its All-Time High Again?

There might be a path to get there again, but don't hold your breath.

NVAX : 53.42 (-8.57%)
4 Growth Stocks Billionaire Money Managers Piled Into During the First Quarter

A turbulent market didn't scare successful money managers away from buying shares in these fast-paced companies.

FB : 193.54 (+1.18%)
NIO : 16.44 (-1.32%)
DDOG : 94.79 (-1.80%)
NVAX : 53.42 (-8.57%)
Could Novavax's Next Step Make It a Multibagger?

The stock is starting off from a particularly low point.

NVAX : 53.42 (-8.57%)
3 Reasons That Novavax Investors Could Be Looking For The Door

Not enough is going right, and there's plenty going awry.

NVAX : 53.42 (-8.57%)
This Is the Most Important Number From Novavax's Q1 Earnings

Novavax is doing well now, but what about the future?

PFE : 52.47 (+3.59%)
NVAX : 53.42 (-8.57%)
Here's Why June Could Make Or Break These 3 Vaccine Stocks

A slew of regulatory catalysts could bring delight -- or disaster.

MRNA : 136.25 (-4.97%)
PFE : 52.47 (+3.59%)
NVAX : 53.42 (-8.57%)
3 Stocks Ready to Bounce Back

The stocks have dropped -- but business is booming.

NVAX : 53.42 (-8.57%)
AMZN : 2,151.82 (+0.25%)
TSLA : 663.90 (-6.42%)
Why Novavax Stock Is Plunging Again Today

The sell-off after Novavax's Q1 update continues.

NVAX : 53.42 (-8.57%)
This 1 Thing Could Make Novavax a Vaccine Leader

It's all about the coronavirus market of the future.

PFE : 52.47 (+3.59%)
NVAX : 53.42 (-8.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Novavax, Inc. is a biotechnology company engaged in developing innovative vaccines to prevent serious infectious diseases. The company is also developing proprietary immune stimulating saponin-based adjuvants, namely Matrix-M, which already enhanced immune responses and were well-tolerated in multiple...

See More

Key Turning Points

3rd Resistance Point 65.47
2nd Resistance Point 61.19
1st Resistance Point 57.30
Last Price 53.42
1st Support Level 49.14
2nd Support Level 44.86
3rd Support Level 40.98

See More

52-Week High 277.80
Fibonacci 61.8% 187.47
Fibonacci 50% 159.56
Fibonacci 38.2% 131.66
Last Price 53.42
52-Week Low 41.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar